Viewing nowRosuvastatin Calcium Tablet 20 mg (Unformulated)
Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

MFDS item code 201400452 · Approved 2014.01.29 · Insurance code 657202680
Treatment of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medication is used as an adjunct when dietary control and exercise are insufficient in patients with various forms of hyperlipidemia, including primary hypercholesterolemia and mixed hyperlipidemia, as well as familial hypercholesterolemia. It helps lower total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It is particularly effective in controlling cholesterol levels in adolescent patients with heterozygous familial hypercholesterolemia. Additionally, it is used as an adjunct in patients with primary dysbetalipoproteinemia. Furthermore, in men over 50 years and women over 60 years with additional risk factors such as hypertension, low HDL, and smoking, it also aids in the reduction of risks for stroke, myocardial infarction, and arterial revascularization. This medication is used to reduce the risk of cardiovascular disease and improve heart health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is required. 4. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but exposure was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients, such as those with allergies to this medication, severe liver dysfunction, muscle disorders, those taking certain drugs, severely impaired renal function, or women who are pregnant or nursing. Additionally, this medication should be used with caution in patients with a history of significant alcohol consumption or liver disease, and regular liver function tests should be conducted during treatment. If symptoms such as muscle pain or weakness occur, the doctor should be notified immediately, and in severe cases, discontinuation of the medication may be necessary. This medication may raise blood sugar levels in some patients, so those at risk of diabetes should closely manage their blood sugar. Furthermore, genetic factors may influence the drug's effects or side effects, so the dosage should be adjusted according to a doctor’s instructions. It is rare for severe skin reactions or liver damage to occur during medication use, so if symptoms such as skin rash, jaundice, or severe fatigue arise, immediate consultation with healthcare professionals is advised. This medication may interact with other drugs, so if there are other medications being taken, healthcare professionals should be informed, especially since muscle-related side effect risks may increase when taken with specific antivirals, immunosuppressants, antifungals, and antibiotics. Women who are pregnant or planning to become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately and a doctor consulted. It is also advisable to avoid this medication while nursing. In case of overdose, there are no specific antidotes, and treatment should be based on symptoms while regularly checking liver function and muscle enzyme levels. Caution is advised when driving or operating machinery due to the potential for dizziness from this medication. Finally, this medication contains lactose, so patients with lactose intolerance should not use it.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, appetite loss, abdominal distension, syncope, widespread pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer period.
Pink round film-coated tablet
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.